BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220310T090000
DTEND;TZID=America/Vancouver:20220310T101500
DTSTAMP:20260404T153754
CREATED:20220307T190200Z
LAST-MODIFIED:20220307T190200Z
UID:27815-1646902800-1646907300@scienceinboston.com
SUMMARY:Harvard Startup Stories: Beacon Bio
DESCRIPTION:Hop on Zoom for this lunchtime talk featuring the founder of Beacon Bio\, a biomedical device startup which launched to commercialize innovations developed at Harvard SEAS\, Harvard’s Wyss Institute\, and Mass Eye & Ear. \nFeatured speaker: \nNicole Black\, PhD ’20\, founder and CEO of Beacon Bio and now Vice President of Biomaterials and Innovation at Desktop Health. \nDr. Black founded Beacon Bio to commercialize a biomimetic hearing-restoration technology developed at Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS)\, the Wyss Institute for Biologically Inspired Engineering at Harvard University\, and Mass Eye & Ear. Dr. Black had advanced this research as a SEAS doctoral student in the lab of Prof. Jennifer Lewis\, and the work was advanced toward commercialization as an Institute Project at the Wyss. The core technology\, called the PhonoGraft device\, is a 3D-printed\, biocompatible graft that could be implanted to repair a damaged eardrum. If its clinical development is successful\, the PhonoGraft technology could mitigate the pain\, drainage\, and hearing loss associated with ear drum perforations that affect millions of individuals worldwide. Shortly after its launch\, Beacon Bio was acquired by California-based Desktop Health\, a healthcare business within Desktop Metal Inc. that focuses on new 3D printing and biofabrication solutions for personalized medicine. Dr. Black\, who was CEO of Beacon Bio and is a Wyss Lumineer\, continues to lead the platform as Vice President of Biomaterials and Innovation at Desktop Health. Read more about the launch and acquisition of Beacon Bio. \nShe will be joined by Chris Petty\, PhD\, Director of Business Development in Harvard Office of Technology Development.
URL:https://scienceinboston.com/event/harvard-startup-stories-beacon-bio-2/
LOCATION:Online
END:VEVENT
END:VCALENDAR